These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 28100612
1. Sex-Dependent Intestinal Replication of an Enteric Virus. Robinson CM, Wang Y, Pfeiffer JK. J Virol; 2017 Apr 01; 91(7):. PubMed ID: 28100612 [Abstract] [Full Text] [Related]
2. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine. Su R, Shereen MA, Zeng X, Liang Y, Li W, Ruan Z, Li Y, Liu W, Liu Y, Wu K, Luo Z, Wu J. mBio; 2020 Nov 17; 11(6):. PubMed ID: 33203755 [Abstract] [Full Text] [Related]
3. Testosterone Promotes the Intestinal Replication and Dissemination of Coxsackievirus B3 in an Oral Inoculation Mouse Model. Dhalech AH, Corn CM, Mangale V, Syed F, Condotta SA, Richer MJ, Robinson CM. J Virol; 2022 Sep 14; 96(17):e0123222. PubMed ID: 36037480 [Abstract] [Full Text] [Related]
4. Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice. Robinson CM, Woods Acevedo MA, McCune BT, Pfeiffer JK. J Virol; 2019 Dec 01; 93(23):. PubMed ID: 31511379 [Abstract] [Full Text] [Related]
5. Specific Bacterial Cell Wall Components Influence the Stability of Coxsackievirus B3. Dhalech AH, Fuller TD, Robinson CM. J Virol; 2021 Oct 27; 95(22):e0142421. PubMed ID: 34431699 [Abstract] [Full Text] [Related]
6. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections. Maciejewski S, Nguyen JH, Gómez-Herreros F, Cortés-Ledesma F, Caldecott KW, Semler BL. mBio; 2015 Dec 29; 7(1):e01931-15. PubMed ID: 26715620 [Abstract] [Full Text] [Related]
7. Rapid Dissemination and Monopolization of Viral Populations in Mice Revealed Using a Panel of Barcoded Viruses. McCune BT, Lanahan MR, tenOever BR, Pfeiffer JK. J Virol; 2020 Jan 06; 94(2):. PubMed ID: 31666382 [Abstract] [Full Text] [Related]
8. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. Weithauser A, Bobbert P, Antoniak S, Böhm A, Rauch BH, Klingel K, Savvatis K, Kroemer HK, Tschope C, Stroux A, Zeichhardt H, Poller W, Mackman N, Schultheiss HP, Rauch U. J Am Coll Cardiol; 2013 Nov 05; 62(19):1737-45. PubMed ID: 23871888 [Abstract] [Full Text] [Related]
9. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3. Wang Y, Pfeiffer JK. mBio; 2016 Mar 29; 7(2):e00119. PubMed ID: 27025249 [Abstract] [Full Text] [Related]
10. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production. Liu H, Li M, Song Y, Xu W. Front Immunol; 2018 Mar 29; 9():2479. PubMed ID: 30410495 [Abstract] [Full Text] [Related]
11. Microbiota-independent antiviral effects of antibiotics on poliovirus and coxsackievirus. Woods Acevedo MA, Pfeiffer JK. Virology; 2020 Jul 29; 546():20-24. PubMed ID: 32452414 [Abstract] [Full Text] [Related]
12. Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells. Nakamura Y, Sakudo A, Saeki K, Kaneko T, Matsumoto Y, Toniolo A, Itohara S, Onodera T. J Gen Virol; 2003 Dec 29; 84(Pt 12):3495-3502. PubMed ID: 14645931 [Abstract] [Full Text] [Related]
13. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice. Koestner W, Spanier J, Klause T, Tegtmeyer PK, Becker J, Herder V, Borst K, Todt D, Lienenklaus S, Gerhauser I, Detje CN, Geffers R, Langereis MA, Vondran FWR, Yuan Q, van Kuppeveld FJM, Ott M, Staeheli P, Steinmann E, Baumgärtner W, Wacker F, Kalinke U. PLoS Pathog; 2018 Aug 29; 14(8):e1007235. PubMed ID: 30075026 [Abstract] [Full Text] [Related]
15. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice. He F, Yao H, Wang J, Xiao Z, Xin L, Liu Z, Ma X, Sun J, Jin Q, Liu Z. J Virol; 2015 Jan 15; 89(2):908-16. PubMed ID: 25339771 [Abstract] [Full Text] [Related]
16. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line. Harrath R, Bourlet T, Delézay O, Douche-Aourik F, Omar S, Aouni M, Pozzetto B. J Med Virol; 2004 Oct 15; 74(2):283-90. PubMed ID: 15332278 [Abstract] [Full Text] [Related]
18. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection. Hühn MH, McCartney SA, Lind K, Svedin E, Colonna M, Flodström-Tullberg M. Virology; 2010 May 25; 401(1):42-8. PubMed ID: 20206372 [Abstract] [Full Text] [Related]
19. Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells. Ullmer W, Semler BL. mBio; 2018 Sep 04; 9(5):. PubMed ID: 30181254 [Abstract] [Full Text] [Related]
20. Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3. Henke A, Zell R, Martin U, Stelzner A. Virology; 2003 Oct 25; 315(2):335-44. PubMed ID: 14585336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]